Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Free Cash Flow of -$2.4 million for Q1 2026, up 21.88% year-on-year from -$2.0 million in Q1 2025, and up 46.87% on a QoQ basis from -$4.6 million in Q4 2025.
Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Free Cash Flow for 4 consecutive years, with -$2.4 million the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow rose 21.88% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.7 million (down 20.84% YoY) and the FY2025 annual result came in at -$12.5 million, up 22.34% from the prior year.
- Free Cash Flow climbed to -$2.4 million in Q1 2026 per IXHL's latest filing, from -$4.6 million in the prior quarter.
- Over the last five years, Free Cash Flow for IXHL reached as high as -$1.5 million in Q2 2025 and fell as low as -$9.2 million in Q3 2025.
- A 4-year average of -$3.9 million and a median of -$3.1 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2024 — Free Cash Flow soared 62.4% — and 2025, when it tumbled 309.89%.
- Year by year, Free Cash Flow stood at -$2.2 million in 2023, then plunged by 161.56% to -$5.7 million in 2024, then gained by 18.59% to -$4.6 million in 2025, then soared by 46.87% to -$2.4 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$2.4 million, -$4.6 million, and -$9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Dec 31, 2023 | -2.16 Mn |
| Dec 31, 2023 | -2.16 Mn |